Πέμπτη 18 Μαΐου 2017

ALK+ lung cancer patients have better prospects of disease control after crizotinib with newly approved brigantinib… https://t.co/XC2Llf3Pe6

ALK+ lung cancer patients have better prospects of disease control after crizotinib with newly approved brigantinib… https://t.co/XC2Llf3Pe6

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/865207887806832640
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις